Advertisement
Screener

ABSCI CORP (ABSI) Cash Flow Breakdown

ABSCI CORP Cash Flow Breakdown

Cash flow breakdown shows where ABSCI CORP's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $92.92M went out.
  • Fiscal year ended 2025-12-31: from investing, $50.16M went out.
  • Fiscal year ended 2025-12-31: from financing, $105.95M came in.
  • Fiscal year ended 2025-12-31: change in cash, $37.14M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew shares soldNot split outChange in cash
2025-12-31-$92.92M-$50.16M-$3.12M*$105.83M-$37.14M
2024-12-31-$72.40M-$41.58M-$3.39M*$82.40M-$31.45M
2023-12-31-$64.64M$81.94M-$3.01M$862.00K-$2.33M*$12.82M
2022-12-31-$81.34M-$126.98M-$4.65M$656.00K$9.23M*-$203.08M
2021-12-31-$60.60M-$67.38M-$1.60M$210.40M$127.40M*$208.22M
2020-12-31-$10.97M-$2.17M-$500.00K$0.00$71.47M*$57.83M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew shares soldNot split outChange in cash
2026-06-30-$27.56M*$24.07M*-$263.00K*$98.14M*$4.85M*
2026-03-31-$26.31M$7.36M-$460.00K$7.96M-$11.39M
2025-12-31-$29.18M*$19.55M*-$498.00K*$3.50M*
2025-09-30-$25.03M*-$63.70M*-$776.00K*$60.65M*
2025-06-30-$16.87M*$9.04M*-$1.08M*$0.00*
2025-03-31-$21.84M-$15.04M-$762.00K$41.69M$1.87M*$5.91M
2024-12-31-$16.96M*$19.04M*-$899.00K*-$2.21M*$4.09M*
2024-09-30-$20.73M*$14.81M*-$816.00K*$1.39M*
2024-06-30-$16.84M*$1.25M*-$801.00K*$2.39M*-$1.72M*
2024-03-31-$17.86M-$76.68M-$872.00K*$80.83M-$13.36M
2023-12-31-$14.92M*$18.96M*-$844.00K*$137.00K*
2023-09-30-$10.36M*$20.14M*-$761.00K*$380.00K*
2023-06-30-$19.23M*$70.15M*-$745.00K*$116.00K*
2023-03-31-$20.12M-$27.30M-$662.00K$229.00K*-$48.52M
2022-12-31-$18.57M*-$30.18M*-$565.00K*$66.00K*$1.89M*
2022-09-30-$19.04M*-$78.72M*-$388.00K*$162.00K*-$695.00K*
2022-06-30-$22.58M*-$11.22M*-$3.10M*$215.00K*$8.71M*
2022-03-31-$21.15M-$6.86M-$600.00K$213.00K*-$29.06M
2021-12-31-$17.08M*-$8.32M*-$600.00K*$71.00K*-$767.00K*
2021-09-30-$21.75M*-$6.82M*-$861.00K*$210.26M*-$1.01M*
2021-06-30-$14.49M*-$43.37M*-$139.00K*$69.00K*
2021-03-31-$7.29M-$8.88M$0.00$0.00$129.58M*$113.42M
2020-12-31-$2.52M*-$910.00K*$0.00*$0.00*$64.39M*
2020-09-30-$2.71M*-$735.00K*$0.00*$0.00*

Similar stocks

Stock NameCountryMarket CapPE Ratio
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14